Search Results - "CUCCHI, Ulisse"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3

    An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma by Sano, Renata, Krytska, Kateryna, Larmour, Colleen E, Raman, Pichai, Martinez, Daniel, Ligon, Gwenda F, Lillquist, Jay S, Cucchi, Ulisse, Orsini, Paolo, Rizzi, Simona, Pawel, Bruce R, Alvarado, Diego, Mossé, Yael P

    Published in Science translational medicine (13-03-2019)
    “…Enthusiasm for the use of antibody-drug conjugates (ADCs) in cancer therapy has risen over the past few years. The success of this therapeutic approach relies…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Abstract 5805: A novel platform of diversified payloads to drive ADC innovation by Orsini, Paolo, Salsa, Matteo, Rizzi, Simona, Cucchi, Ulisse, Faiardi, Daniela, Burocchi, Alessia, Ciavolella, Antonella, Lupi, Rosita, Gasparri, Fabio, Valsasina, Barbara

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract First generation of antibody drug conjugates (ADCs) for anticancer therapy has been described more than two decades ago with gemtuzumab-ozogamicin…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Thiol-peptide level and proteomic changes in response to cadmium toxicity in Oryza sativa L. roots by Aina, Roberta, Labra, Massimo, Fumagalli, Pietro, Vannini, Candida, Marsoni, Milena, Cucchi, Ulisse, Bracale, Marcella, Sgorbati, Sergio, Citterio, Sandra

    “…In the present study, rice seedlings were exposed to a range of Cd concentrations (0.1 μM, 1 μM, 10 μM, 100 μM and 1 mM) for 15 days and a combination of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Structural Insight into Maternal Embryonic Leucine Zipper Kinase (MELK) Conformation and Inhibition toward Structure-Based Drug Design by Canevari, Giulia, Re Depaolini, Stefania, Cucchi, Ulisse, Bertrand, Jay A, Casale, Elena, Perrera, Claudia, Forte, Barbara, Carpinelli, Patrizia, Felder, Eduard R

    Published in Biochemistry (Easton) (17-09-2013)
    “…Maternal embryonic leucine zipper kinase (MELK) is upregulated in several types of tumor, including breast, prostate, and brain tumors. Its expression is…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Abstract 2690: A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma by Sano, Renata, Krytska, Kateryna, Larmour, Colleen, Ligon, Gwenda F., Lillquist, Jay S., Cucchi, Ulisse, Orsini, Paolo, Rizzi, Simona, McMahon, Gerald, Alvarado, Diego, Mosse, Yael P.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Activated ALK by mutation or amplification is a validated therapeutic target in a subset of patients with high-risk neuroblastoma, and tyrosine kinase…”
    Get full text
    Journal Article
  13. 13

    Phosphorylation of TCTP as a Marker for Polo-like Kinase-1 Activity In Vivo by CUCCHI, Ulisse, GIANELLINI, Laura M, GIORGINI, Maria L, CAPPELLA, Paolo, BERIA, Italo, VALSASINA, Barbara, DE PONTI, Anna, SOLA, Francesco, ALZANI, Rachele, PATTON, Veronica, PEZZONI, Alice, TROIANI, Sonia, SACCARDO, Maria B, RIZZI, Simona

    Published in Anticancer research (01-12-2010)
    “…Polo-like kinase 1 (PLK1) is the master regulator of mitosis and a target for anticancer therapy. To develop a marker of PLK1 activity in cells and tumour…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18